185 related articles for article (PubMed ID: 15295615)
21. Macrophages infiltrating the tissue in chronic pancreatitis express the chemokine receptor CCR5.
Goecke H; Forssmann U; Uguccioni M; Friess H; Conejo-Garcia JR; Zimmermann A; Baggiolini M; Büchler MW
Surgery; 2000 Nov; 128(5):806-14. PubMed ID: 11056444
[TBL] [Abstract][Full Text] [Related]
22. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
Princen K; Schols D
Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
[TBL] [Abstract][Full Text] [Related]
23. Activation of beta-chemokines and CCR5 in persons infected with human immunodeficiency virus type 1 and tuberculosis.
Mayanja-Kizza H; Wajja A; Wu M; Peters P; Nalugwa G; Mubiru F; Aung H; Vanham G; Hirsch C; Whalen C; Ellner J; Toossi Z
J Infect Dis; 2001 Jun; 183(12):1801-4. PubMed ID: 11372034
[TBL] [Abstract][Full Text] [Related]
24. Complexity in human immunodeficiency virus type 1 (HIV-1) co-receptor usage: roles of CCR3 and CCR5 in HIV-1 infection of monocyte-derived macrophages and brain microglia.
Agrawal L; Maxwell CR; Peters PJ; Clapham PR; Liu SM; Mackay CR; Strayer DS
J Gen Virol; 2009 Mar; 90(Pt 3):710-722. PubMed ID: 19218218
[TBL] [Abstract][Full Text] [Related]
25. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis.
Badewa AP; Quinton LJ; Shellito JE; Mason CM
Tuberculosis (Edinb); 2005 May; 85(3):185-95. PubMed ID: 15850756
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of M-tropic HIV-1 infection by the fd phage-gene 3 protein with MIP-1alpha-binding activity.
Meta A; Torigoe N; Ito Y; Arakaki R; Nakashima H; Sugimura K
Mol Immunol; 1999 Dec; 36(18):1249-54. PubMed ID: 10684964
[TBL] [Abstract][Full Text] [Related]
27. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
[TBL] [Abstract][Full Text] [Related]
28. The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.
Menten P; Struyf S; Schutyser E; Wuyts A; De Clercq E; Schols D; Proost P; Van Damme J
J Clin Invest; 1999 Aug; 104(4):R1-5. PubMed ID: 10449444
[TBL] [Abstract][Full Text] [Related]
29. Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.
Guan Y; Abdelwahab S; Kamin-Lewis R; DeVico AL; Lewis GK
PLoS One; 2008; 3(10):e3481. PubMed ID: 18941536
[TBL] [Abstract][Full Text] [Related]
30. The seventh transmembrane domain of cc chemokine receptor 5 is critical for MIP-1beta binding and receptor activation: role of MET 287.
Youn BS; Yu KY; Alkhatib G; Kwon BS
Biochem Biophys Res Commun; 2001 Mar; 281(3):627-33. PubMed ID: 11237703
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts.
Cagnon L; Rossi JJ
Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):251-61. PubMed ID: 10984119
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
[TBL] [Abstract][Full Text] [Related]
33. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis.
Zhou Y; Huang D; Farver C; Hoffman GS
J Rheumatol; 2003 Jul; 30(7):1541-7. PubMed ID: 12858455
[TBL] [Abstract][Full Text] [Related]
34. Recall antigen activation induces prompt release of CCR5 ligands from PBMC: implication in memory responses and immunization.
Sun L; Abdelwahab SF; Lewis GK; Garzino-Demo A
Int Immunol; 2004 Nov; 16(11):1623-31. PubMed ID: 15466454
[TBL] [Abstract][Full Text] [Related]
35. Monocyte chemoattractant protein-2 (CC chemokine ligand 8) inhibits replication of human immunodeficiency virus type 1 via CC chemokine receptor 5.
Yang OO; Garcia-Zepeda EA; Walker BD; Luster AD
J Infect Dis; 2002 Apr; 185(8):1174-8. PubMed ID: 11930329
[TBL] [Abstract][Full Text] [Related]
36. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
37. gammadeltaT cell-mediated regulation of chemokine producing macrophages during Listeria monocytogenes infection-induced inflammation.
Tramonti D; Rhodes K; Martin N; Dalton JE; Andrew E; Carding SR
J Pathol; 2008 Oct; 216(2):262-70. PubMed ID: 18767021
[TBL] [Abstract][Full Text] [Related]
38. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection.
Mack M; Kleinschmidt A; Brühl H; Klier C; Nelson PJ; Cihak J; Plachý J; Stangassinger M; Erfle V; Schlöndorff D
Nat Med; 2000 Jul; 6(7):769-75. PubMed ID: 10888925
[TBL] [Abstract][Full Text] [Related]
39. Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.
Lin YL; Mettling C; Portales P; Reynes J; Clot J; Corbeau P
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15590-5. PubMed ID: 12434015
[TBL] [Abstract][Full Text] [Related]
40. RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy.
Li M; Li H; Rossi JJ
Ann N Y Acad Sci; 2006 Oct; 1082():172-9. PubMed ID: 17145937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
